Shelter Pharma Bags Contract from Berlin International Medical: Detailed Terms and Conditions

Shelter Pharma Secures Major Order from Berlin International Medical: Key Details Revealed

Team FS

06/Jun/2024

Key Points:

1: Shelter Pharma secures a significant order contract from Berlin International Medical, an international entity based in Kuwait.

2: The contract includes the supply of pharmaceutical products worth $120,000, to be executed within three months.

3: Neither the promoter nor related parties have any interests in the entity awarding the contract, ensuring transparency and impartiality in the transaction.

Shelter Pharma Limited (SHELTER) has clinched a major contract from Berlin International Medical Co, an esteemed international entity operating out of Kuwait. The contract entails the supply of various pharmaceutical products, highlighting Shelter Pharma's growing presence and capabilities in the global market.

The terms and conditions of the contract outline the specifics of the order, which includes the provision of D3Cure 50 ml x 30,000 pcs, FerroCure Capsule 30,000 pcs, CoughNill 200ml x 10,000 pcs, Stonyl 10,000 pcs, and RoyalForte Capsule 10,000 pcs. These pharmaceutical products are slated for delivery within a period of three months, emphasizing the urgency and efficiency required in fulfilling the order.

With a fixed cost associated with the contract amounting to $120,000, this business deal represents a significant opportunity for Shelter Pharma to expand its international footprint and bolster its revenue streams. The absence of any interests from the promoter, promoter group, or related parties in the entity awarding the contract ensures transparency and impartiality in the transaction.

Furthermore, it's worth noting that the transaction does not fall within related party transactions, and the contract is conducted at arm's length, underscoring the integrity and fairness of the agreement.

In conclusion, Shelter Pharma's successful bid for the contract from Berlin International Medical Co underscores its capability to compete and thrive in the global pharmaceutical landscape. With a commitment to quality and timely delivery, Shelter Pharma continues to solidify its position as a trusted provider of pharmaceutical solutions, catering to the diverse needs of clients worldwide.

Also Read : Orchid Pharma Receives DCGI Approval for New Antibiotic Against Antimicrobial Resistance

Join our Telegram Channel and WhatsApp Channel for regular Updates.

Disclaimer

The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.

Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.

We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.

You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.

By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.

Services

Shelter Pharma Secures Major Order from Berlin International Medical: Key Details Revealed

Related News

Disclaimer